Report Highlights

Did you know that there have been 74 Pharmacy500 mergers and acquisitions (M&A) over the past year?
Source: RXinsider

Take a closer look at RXinsider’s latest M&A pharmacy market report:
• Explore a timeline of Pharmacy500 M&A activity
• Review key aspects of buying and selling a pharmacy
• Dive into a detailed breakdown of M&A services offered and more!

The objective of this report is to educate Pharmacy500 professionals, pharmacy leadership, and other stakeholders on key trends within the supply chain as it relates to pharmacy M&A services.

Pharmacy Mergers & Acquisitions (M&A)

Pharmacy M&A refers to the process of transferring ownership of a pharmacy business from one party (the seller) to another (the buyer). This transaction involves the sale of the pharmacy’s physical assets, intellectual property, inventory, and, in some cases, goodwill, along with the assumption of certain liabilities, depending on the deal terms. The process is often complex, involving legal, financial, regulatory, and operational considerations. The process of buying and selling a pharmacy requires careful planning and execution; it involves substantial financial investment, regulatory compliance, and legal oversight. Partnering with professionals such as attorneys, accountants, and business brokers with experience in healthcare transactions is often critical to ensuring the deal’s success and legality.

1. Valuation

• Assess the pharmacy’s overall value by analyzing tangible assets (inventory, equipment, real estate, fixtures), intangible assets (goodwill, reputation, customer relationships), and financial performance through revenue, profitability, and cash flow analysis.

2. Due Diligence

• Conducting a comprehensive review of the pharmacy’s legal, financial, operational, and regulatory standing includes licensing, financial health, contracts, business operations, staffing, inventory management, and compliance with healthcare and pharmacy regulations.

3. Negotiation and Agreement

• The sales agreement includes a legally binding contract outlining the terms and conditions of the sale, including the purchase price, payment structure (lump sum or installment payments), and any contingencies or warranties.

Executive Snapshot

The following statistics are extracted from the pharmacy M&A Executive Snapshot.

• 18.2% is the average independent pharmacy gross profit margin.

• 34% of pharmacy owners provide monetary support to 10 or more community organizations.

• $5.41M is the average independent pharmacy sales in 2024 per location, up from $4,997,000 in 2023.

Source: Source: NCPA 2025 Digest

Pharmacy500 Market Intelligence Reports

The objective of RXinsider’s weekly Market Intelligence Reports is to educate Pharmacy500 professionals, pharmacy leadership, and other stakeholders on key trends within the supply chain as it relates to the pharmacy industry.

Learn more about RXinsider’s weekly Market Intelligence Reports on our website: RXinsider.com/pharmacy_market_intelligence

Having Trouble Accessing Reports?

Request a two-week trial here.